B6.129P2-Chek2tm1Mak/Cnbc

Status

Available to order

EMMA IDEM:06380
International strain nameB6.129P2-Chek2tm1Mak/Cnbc
Alternative nameChk2
Strain typeTargeted Mutant Strains : Knock-out
Allele/Transgene symbolChek2tm1Mak
Gene/Transgene symbolChek2

Information from provider

ProviderTak W Mak
Provider affiliationMak Lab, Campbell Family Breast Cancer reseach Institute
Genetic informationExons 8 to 11 were replaced with a neomycin cassette (Neo).
Phenotypic informationChk2(-/-) mice do not spontaneously develop tumors, although Chk2 does suppress 7,12-dimethylbenzanthracene-induced skin tumors. Tissues from Chk2(-/-) mice, including those from the thymus, central nervous system, fibroblasts, epidermis, and hair follicles, show significant defects in IR-induced apoptosis or impaired G(1)/S arrest. Quantitative comparison of the G(1)/S checkpoint, apoptosis, and expression of p53 proteins in Chk2(-/-) versus ATM(-/-) thymocytes suggested that Chk2 can regulate p53-dependent apoptosis in an ATM-independent manner.
Breeding historyBackcrossed 10 times to C57BL/6.
References
  • Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner.;Hirao Atsushi, Cheung Alison, Duncan Gordon, Girard Pierre-Marie, Elia Andrew J, Wakeham Andrew, Okada Hitoshi, Sarkissian Talin, Wong Jorge A, Sakai Takashi, De Stanchina Elisa, Bristow Robert G, Suda Toshio, Lowe Scott W, Jeggo Penny A, Elledge Stephen J, Mak Tak W, ;2002;Molecular and cellular biology;22;6521-32; 12192050
  • Inactivation of chk2 and mus81 leads to impaired lymphocytes development, reduced genomic instability, and suppression of cancer.;El Ghamrasni Samah, Pamidi Ashwin, Halaby Marie Jo, Bohgaki Miyuki, Cardoso Renato, Li Li, Venkatesan Shriram, Sethu Swaminathan, Hirao Atsushi, Mak Tak W, Hande Manoor Prakash, Hakem Anne, Hakem Razqallah, ;2011;PLoS genetics;7;e1001385; 21625617
  • Cross-talk between Chk1 and Chk2 in double-mutant thymocytes.;Zaugg Kathrin, Su Yu-Wen, Reilly Patrick T, Moolani Yasmin, Cheung Carol C, Hakem Razquallah, Hirao Atsushi, Liu Qinghua, Elledge Stephen J, Mak Tak W, ;2007;Proceedings of the National Academy of Sciences of the United States of America;104;3805-10; 17360434
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreCNB-CSIC, Centro Nacional de Biotecnologia, Madrid, Spain
Animals used for archivingheterozygous C57BL/6J

Disease and phenotype information

IMPC phenotypes (gene matching)
  • increased circulating sodium level / IMPC
MGI phenotypes (allele matching)
  • decreased cellular sensitivity to ionizing radiation / MGI
  • decreased cellular sensitivity to gamma-irradiation / MGI
  • abnormal cell cycle checkpoint function / MGI
  • increased incidence of tumors by chemical induction / MGI
MGI phenotypes (gene matching)
  • decreased mortality induced by ionizing radiation / MGI
  • abnormal cell cycle / MGI
  • decreased cellular sensitivity to gamma-irradiation / MGI
  • polyploidy / MGI
  • abnormal cell cycle checkpoint function / MGI
  • decreased cellular sensitivity to ionizing radiation / MGI
  • increased incidence of tumors by chemical induction / MGI
  • abnormal cell physiology / MGI

Literature references

  • Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner.;Hirao Atsushi, Cheung Alison, Duncan Gordon, Girard Pierre-Marie, Elia Andrew J, Wakeham Andrew, Okada Hitoshi, Sarkissian Talin, Wong Jorge A, Sakai Takashi, De Stanchina Elisa, Bristow Robert G, Suda Toshio, Lowe Scott W, Jeggo Penny A, Elledge Stephen J, Mak Tak W, ;2002;Molecular and cellular biology;22;6521-32; 12192050
  • Inactivation of chk2 and mus81 leads to impaired lymphocytes development, reduced genomic instability, and suppression of cancer.;El Ghamrasni Samah, Pamidi Ashwin, Halaby Marie Jo, Bohgaki Miyuki, Cardoso Renato, Li Li, Venkatesan Shriram, Sethu Swaminathan, Hirao Atsushi, Mak Tak W, Hande Manoor Prakash, Hakem Anne, Hakem Razqallah, ;2011;PLoS genetics;7;e1001385; 21625617
  • Cross-talk between Chk1 and Chk2 in double-mutant thymocytes.;Zaugg Kathrin, Su Yu-Wen, Reilly Patrick T, Moolani Yasmin, Cheung Carol C, Hakem Razquallah, Hirao Atsushi, Liu Qinghua, Elledge Stephen J, Mak Tak W, ;2007;Proceedings of the National Academy of Sciences of the United States of America;104;3805-10; 17360434

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).